Why and how transwomen are switching to funded oestrogen gel

+Educate
In print
Gender-affirming care

Why and how transwomen are switching to funded oestrogen gel

By Massimo Giola
Arms_crossed
Oestradiol gel is applied to one or both arms [Image: Sincerely Media on Unsplash (edited)]

With oestrogen gel now funded without restrictions, sexual health specialist Massimo Giola explains who would benefit from using it for feminisation and how switching from tablets or patches might occur. This follows his December article on the use of testosterone gel for masculinisation

When prescribing oestrogens to assigned male at birth transgender women or non-binary people seeking feminisation (transwomen from now on, for brevity
References

1. Scheres LJJ, Selier NLD, Nota NM, et al. Effect of gender-affirming hormone use on coagulation profiles in transmen and transwomen. J Thromb Haemost 2021;19(4):1029–37.

2. Coleman E, Radix AE, Bouman WP, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgend Health 2022;23(Suppl 1):S1–259.

3. Veale JF. Transgender-related stigma and gender minority stress-related health disparities in Aotearoa New Zealand: hypercholesterolemia, hypertension, myocardial infarction, stroke, diabetes, and general health. Lancet Reg Health West Pac 2023;39:100816.

4. Australasian Menopause Society. AMS Guide to MHT/HRT Doses New Zealand only. 21 October 2024.